Allogeneic hematopoietic stem cell transplantation from a two HLA-haplotype-mismatched family donor for post-transplant relapse/rejection: A prospective phase II study with statistical validation for survival benefit
Phase 2
- Conditions
- hematologic malignancies relapsing or with rejection after allogeneic hematopoietic stem cell transplantation
- Registration Number
- JPRN-UMIN000043973
- Lead Sponsor
- Hyogo College of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1) serum Cre >2.0 mg/dl 2) serum T-Bil >2.0 mg/dl 3) selum AST and/or ALT >200 U/L 4) EF <45% 5) SpO2 <95% (room air) 6) PS (ECOG score) 3-4
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method